UKPOL.CO.UK

Tag: 2015

  • Catherine McKinnell – 2015 Parliamentary Question to the Department for Environment, Food and Rural Affairs

    Catherine McKinnell – 2015 Parliamentary Question to the Department for Environment, Food and Rural Affairs

    The below Parliamentary question was asked by Catherine McKinnell on 2015-10-09.

    To ask the Secretary of State for Environment, Food and Rural Affairs, how many expressions of interest have been received for the (a) Mid Tier and (b) Higher Tier of the new Countryside Stewardship scheme.

    George Eustice

    Expressions of interest were not invited for the Mid-Tier of the new Countryside Stewardship scheme, however:

    a) 5,640 requests for Mid-Tier application packs were received, resulting in 2,314 agreement applications; and

    b) 1,025 expressions of interest were received for the Higher Tier of the new Countryside Stewardship scheme, together with 257 applications for forestry agreements.

  • Fiona Mactaggart – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    Fiona Mactaggart – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Fiona Mactaggart on 2015-10-09.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, whether he plans to raise the human rights of ethnic and religious minorities in India during the visit of Prime Minister Modi to the UK in November 2015; and if he will make a statement.

    Mr Hugo Swire

    India and the UK have a rich, wide-ranging and mature bilateral relationship. We will discuss a broad spectrum of issues during Prime Minister Modi’s visit.

    The UK raises a range of human rights matters with India, including religious freedom and the treatment of ethnic minorities, both bilaterally and through the EU. This includes meeting Union and State level government institutions, such as the Indian National Commission for Minorities, which the British High Commission in New Delhi met earlier this month. The High Commission also stays in regular contact with civil society organisations and senior faith leaders working on religious freedom across India.

  • Andrew Gwynne – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    Andrew Gwynne – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Andrew Gwynne on 2015-10-09.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what assessment he has made of the potential effect of the UK leaving the EU on relations between Spain and HM Government of Gibraltar.

    Mr David Lidington

    The Prime Minister is focused on delivering a successful renegotiation: he believes he can and will succeed in reforming and renegotiating our relationship with the EU and campaigning to keep the UK in the EU on that basis.

  • Robert Neill – 2015 Parliamentary Question to the Department of Health

    Robert Neill – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Robert Neill on 2015-10-09.

    To ask the Secretary of State for Health, what assessment he has made of the compatibility of recent requests by NHS England to delay implementation of NICE guidance with his Department’s commitment to the three month funding requirement in the latest iteration of the Pharmaceutical Price Regulation Scheme; what steps he is taking to ensure that all positive NICE recommendations are funded within three months; and if he will make a statement.

    George Freeman

    NHS England is specified in the 2014 Pharmaceutical Pricing Regulation Scheme agreement as the body responsible for ensuring there are no local barriers to ensuring access to technologies recommended in National Institute for Health and Care Excellence (NICE) technology appraisal and highly specialised technology guidance.

    NHS England has advised that there are a range of initiatives which assist NHS England in this obligation:

    – NICE technology appraisalrecommendations are required to be incorporated automatically into relevant local medicines formularies;

    – providers are required to publish local medicines formularies;

    – the NICE Implementation Collaborative (NIC) examines barriers to the prompt implementation of NICE guidance;

    – an innovation scorecard is published quarterly by the Health and Social Care Information Centre and tracks uptake of many NICE-approved medicines by the NHS;

    – a joint NHS England and Association of the British Pharmaceutical Industry work programme on medicines optimisation is ongoing, which seeks to improve outcomes and value from all medicines;

    – NHS England works closely with Academic Health Science Networks to accelerate the adoption and diffusion of innovation.

    The Department’s analysis of medicines spend for the first year of the PPRS shows that branded medicines spend grew by 8.2%, with new medicines on the Innovation Scorecard seeing growth of 18.4%. Further details have been published on the Government’s website at:

    https://www.gov.uk/government/publications/analysis-of-growth-in-branded-medicines-2013-to-2014

    Commissioners are legally required to fund drugs and treatments recommended in NICE technology appraisal and highly specialised technology guidance within three months of NICE’s guidance being published. There is provision for this funding period to be extended where there are particular barriers to implementation within three months.

    “

  • Liam Byrne – 2015 Parliamentary Question to the Department of Health

    Liam Byrne – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Liam Byrne on 2015-10-09.

    To ask the Secretary of State for Health, when the consultation on the Public Health Outcomes Framework 2016-17 will begin.

    Jane Ellison

    The consultation on updating the Public Health Outcomes Framework was published on 3 September and closed on 2 October. We are considering the responses and intend to publish our proposals in due course.

  • Keith Vaz – 2015 Parliamentary Question to the Department of Health

    Keith Vaz – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Keith Vaz on 2015-10-09.

    To ask the Secretary of State for Health, what estimate he has made of the number of people (a) diagnosed and (b) currently undiagnosed with diabetes in (i) England, (ii) Wales, (iii) Scotland and (iv) Northern Ireland.

    Jane Ellison

    The information on estimates of people in each county who have diabetes is not available in the format requested. The table below shows the estimated number of people with diabetes for upper tier district authorities. The estimates ranges from 5.4% in the City of London, to 10.7% in Brent.

    Estimated ranges of people with diabetes for upper tier district authorities for 2014

    2014

    Number

    Prevalence

    England

    3,279,925

    7.5%

    Buckinghamshire CC

    28,986

    7.1%

    Cambridgeshire CC

    35,215

    6.7%

    Cumbria CC

    33,879

    8.0%

    Derbyshire CC

    48,864

    7.6%

    Devon CC

    52,629

    8.1%

    Dorset CC

    30,060

    8.7%

    East Sussex CC

    37,859

    8.6%

    Essex CC

    87,202

    7.2%

    Gloucestershire CC

    36,877

    7.4%

    Hampshire CC

    77,073

    7.1%

    Hertfordshire CC

    62,079

    6.8%

    Kent CC

    90,195

    7.5%

    Lancashire CC

    76,349

    7.8%

    Leicestershire CC

    40,535

    7.4%

    Lincolnshire CC

    48,338

    8.0%

    Norfolk CC

    59,406

    7.9%

    Northamptonshire CC

    41,475

    7.1%

    North Yorkshire CC

    39,207

    7.7%

    Nottinghamshire CC

    49,494

    7.5%

    Oxfordshire CC

    35,376

    6.6%

    Somerset CC

    36,052

    8.0%

    Staffordshire CC

    52,956

    7.6%

    Suffolk CC

    47,835

    7.7%

    Surrey CC

    62,828

    6.8%

    Warwickshire CC

    34,255

    7.5%

    West Sussex CC

    52,761

    7.8%

    Worcestershire CC

    36,287

    7.8%

    City of London LB

    693

    5.4%

    Barking and Dagenham LB

    9,942

    7.5%

    Barnet LB

    23,493

    8.2%

    Bexley LB

    13,716

    7.3%

    Brent LB

    21,497

    10.7%

    Bromley LB

    18,676

    7.2%

    Camden LB

    12,758

    6.1%

    Croydon LB

    23,737

    8.5%

    Ealing LB

    22,765

    8.8%

    Enfield LB

    19,233

    8.2%

    Greenwich LB

    13,330

    7.3%

    Hackney LB

    13,882

    8.1%

    Hammersmith and Fulham LB

    9,120

    6.5%

    Haringey LB

    14,316

    7.7%

    Harrow LB

    18,567

    9.6%

    Havering LB

    14,746

    7.5%

    Hillingdon LB

    16,509

    7.6%

    Hounslow LB

    16,311

    8.3%

    Islington LB

    10,389

    6.3%

    Kensington and Chelsea LB

    11,515

    7.6%

    Kingston upon Thames LB

    9,119

    6.2%

    Lambeth LB

    16,069

    6.6%

    Lewisham LB

    15,799

    7.1%

    Merton LB

    11,751

    6.6%

    Newham LB

    17,950

    10.1%

    Redbridge LB

    19,326

    8.8%

    Richmond upon Thames LB

    10,345

    6.3%

    Southwark LB

    16,709

    6.5%

    Sutton LB

    11,149

    6.9%

    Tower Hamlets LB

    14,360

    7.2%

    Waltham Forest LB

    14,919

    8.5%

    Wandsworth LB

    14,232

    5.8%

    Westminster LB

    15,354

    6.4%

    Bolton MD

    17,905

    8.4%

    Bury MD

    11,054

    7.5%

    Manchester MD

    27,051

    6.5%

    Oldham MD

    14,368

    8.4%

    Rochdale MD

    13,608

    8.4%

    Salford MD

    13,212

    6.9%

    Stockport MD

    17,225

    7.4%

    Tameside MD

    14,001

    7.9%

    Trafford MD

    12,732

    7.2%

    Wigan MD

    18,785

    7.4%

    Knowsley MD

    9,246

    7.7%

    Liverpool MD

    26,281

    7.1%

    St Helens MD

    11,119

    7.6%

    Sefton MD

    17,851

    8.0%

    Wirral MD

    19,508

    7.9%

    Barnsley MD

    14,456

    7.6%

    Doncaster MD

    18,782

    7.9%

    Rotherham MD

    16,434

    7.8%

    Sheffield MD

    33,060

    7.0%

    Gateshead MD

    12,158

    7.6%

    Newcastle upon Tyne MD

    16,034

    6.6%

    North Tyneside MD

    12,242

    7.3%

    South Tyneside MD

    9,982

    7.8%

    Sunderland MD

    17,552

    7.5%

    Birmingham MD

    72,576

    8.8%

    Coventry MD

    20,609

    7.9%

    Dudley MD

    20,361

    8.0%

    Sandwell MD

    22,244

    9.5%

    Solihull MD

    13,109

    7.7%

    Walsall MD

    18,340

    9.0%

    Wolverhampton MD

    19,090

    9.8%

    Bradford MD

    35,136

    8.5%

    Calderdale MD

    12,987

    7.7%

    Kirklees MD

    27,064

    8.1%

    Leeds MD

    45,596

    6.5%

    Wakefield MD

    20,763

    7.6%

    Hartlepool UA

    5,690

    7.6%

    Middlesbrough UA

    8,791

    7.7%

    Redcar and Cleveland UA

    9,121

    8.1%

    Stockton-on-Tees UA

    11,330

    7.1%

    Darlington UA

    6,314

    7.6%

    County Durham UA

    32,455

    7.6%

    Northumberland UA

    21,048

    8.0%

    Cheshire East UA

    22,235

    7.3%

    Halton UA

    7,168

    7.5%

    Warrington UA

    11,560

    7.0%

    Cheshire West and Chester UA

    19,617

    7.2%

    Blackburn with Darwen UA

    9,525

    8.9%

    Blackpool UA

    9,541

    8.4%

    Kingston upon Hull UA

    15,411

    6.8%

    East Riding of Yorkshire UA

    23,168

    7.8%

    North East Lincolnshire UA

    9,927

    7.7%

    North Lincolnshire UA

    10,872

    7.9%

    York UA

    10,873

    6.1%

    Derby UA

    15,433

    7.5%

    Leicester UA

    24,459

    9.5%

    Rutland UA

    2,379

    7.5%

    Nottingham UA

    16,958

    6.4%

    Herefordshire County UA

    12,831

    8.4%

    Telford and Wrekin UA

    9,834

    7.4%

    Shropshire UA

    19,867

    8.0%

    Stoke-on-Trent UA

    15,358

    7.9%

    Bath and North East Somerset UA

    9,907

    6.4%

    Bristol UA

    23,189

    5.9%

    North Somerset UA

    14,094

    7.6%

    South Gloucestershire UA

    14,422

    6.3%

    Cornwall UA

    37,893

    8.1%

    Plymouth UA

    14,805

    6.7%

    Torbay UA

    9,947

    8.6%

    Bournemouth UA

    10,006

    7.1%

    Poole UA

    9,052

    7.6%

    Swindon UA

    11,443

    6.7%

    Wiltshire UA

    27,724

    7.2%

    Peterborough UA

    10,850

    7.6%

    Luton UA

    12,685

    8.2%

    Bedford UA

    10,228

    7.7%

    Central Bedfordshire UA

    14,494

    6.7%

    Southend-on-Sea UA

    10,646

    7.7%

    Thurrock UA

    8,951

    6.7%

    Medway UA

    14,548

    7.0%

    Bracknell Forest UA

    5,833

    6.1%

    West Berkshire UA

    8,445

    6.7%

    Reading UA

    7,789

    6.0%

    Slough UA

    9,181

    8.8%

    Windsor and Maidenhead UA

    8,256

    6.9%

    Wokingham UA

    8,408

    6.1%

    Milton Keynes UA

    13,397

    6.7%

    Brighton and Hove UA

    13,933

    6.3%

    Portsmouth UA

    10,862

    6.1%

    Southampton UA

    12,622

    6.0%

    Isle of Wight UA

    10,614

    8.5%

    Source: Yorkshire and Humber Public Health Observatory Diabetes Prevalence Model

    Diagnosed diabetes prevalence across the four nations of the United Kingdom are taken from the Quality and Outcomes Framework (QOF) and represents all patients age 17 and older who have been diagnosed with diabetes and included on general practitioner registers.

    In 2013/14, QOF showed that there were 3.3 million people aged 17 years and older with diagnosed diabetes with equals 6.2% of this age group. The break down by country can be found in the following table:

    Diagnosed diabetes across the four nations of the United Kingdom -2013/14

    Number

    %

    England

    2,814,004

    6.2%

    Wales

    177,212

    6.9%

    Scotland

    259,986

    5.9%

    Northern Ireland

    81,867

    5.3%

    United Kingdom

    3,333,069

    6.2%

    Source: Quality and Outcomes Framework (Health and Social Care Information Centre)

    Public Health England’s diabetes prevalence model estimates total diabetes prevalence for England and for all local authorities and clinical commissioning groups in England. The model reflects the prevalence of diabetes (diagnosed and undiagnosed) and adjusts for the age, sex, ethnic group and deprivation pattern of the local population.

    The estimated total diabetes prevalence using the diabetes prevalence model is 7.5% in England in 2014.

  • Sharon Hodgson – 2015 Parliamentary Question to the Department of Health

    Sharon Hodgson – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Sharon Hodgson on 2015-10-09.

    To ask the Secretary of State for Health, which Minister in his Department is leading on infant feeding policy; for what reasons England has no ministerial infant feeding lead; and for what reasons England does not have a national infant feeding committee with measurable targets as suggested for all member states as part of the WHO Global Strategy on Infant and Young Child Feeding.

    Ben Gummer

    As Parliamentary Under Secretary of State for Care Quality I have responsibility for breastfeeding (also called infant feeding) policy as I am the lead for maternity policy more widely. In addition, for clarity, the Parliamentary Under Secretary of State for Public Health (Jane Ellison) leads on the related area of children’s health and also has responsibility for health visitors.

    The Department hosts a National Infant Feeding Steering Group which meets quarterly to promote evidence based policy and practice through communication and information sharing.

    The Government is committed to supporting breastfeeding through the Healthy Child Programme. Breastfeeding is included in the Public Health Outcomes Framework so that the improvements can be tracked, and action taken as needed.

  • Matthew Pennycook – 2015 Parliamentary Question to the Department of Health

    Matthew Pennycook – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Matthew Pennycook on 2015-10-09.

    To ask the Secretary of State for Health, what proportion of Improving Access to Psychological Therapies patients in Greenwich and Woolwich constituency waited less than 90 days for treatment in the last 12 months.

    Alistair Burt

    The information is not collected in the format requested.

    The following attachment, Improving Access to Psychological Therapies contains referrals assessed in 28 and 90 days or less and referrals that waited 28 and 90 days or less to enter treatment, as a proportion of all referrals assessed between 1 April 2013 and 31 March 2014, for England and NHS Greenwich Clinical Commissioning Group.

    Data is not published at constituency level.

  • Robert Neill – 2015 Parliamentary Question to the Department of Health

    Robert Neill – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Robert Neill on 2015-10-09.

    To ask the Secretary of State for Health, with reference to page 20 of the 2014 Pharmaceutical Price Regulation Scheme, which body is responsible for ensuring there should be no local barriers to accessing technologies recommended in NICE guidance; what assessment that body has made of the existence of local barriers since 1 January 2014; and if he will make a statement.

    George Freeman

    NHS England is specified in the 2014 Pharmaceutical Pricing Regulation Scheme agreement as the body responsible for ensuring there are no local barriers to ensuring access to technologies recommended in National Institute for Health and Care Excellence (NICE) technology appraisal and highly specialised technology guidance.

    NHS England has advised that there are a range of initiatives which assist NHS England in this obligation:

    – NICE technology appraisalrecommendations are required to be incorporated automatically into relevant local medicines formularies;

    – providers are required to publish local medicines formularies;

    – the NICE Implementation Collaborative (NIC) examines barriers to the prompt implementation of NICE guidance;

    – an innovation scorecard is published quarterly by the Health and Social Care Information Centre and tracks uptake of many NICE-approved medicines by the NHS;

    – a joint NHS England and Association of the British Pharmaceutical Industry work programme on medicines optimisation is ongoing, which seeks to improve outcomes and value from all medicines;

    – NHS England works closely with Academic Health Science Networks to accelerate the adoption and diffusion of innovation.

    The Department’s analysis of medicines spend for the first year of the PPRS shows that branded medicines spend grew by 8.2%, with new medicines on the Innovation Scorecard seeing growth of 18.4%. Further details have been published on the Government’s website at:

    https://www.gov.uk/government/publications/analysis-of-growth-in-branded-medicines-2013-to-2014

    Commissioners are legally required to fund drugs and treatments recommended in NICE technology appraisal and highly specialised technology guidance within three months of NICE’s guidance being published. There is provision for this funding period to be extended where there are particular barriers to implementation within three months.

    “

  • Matthew Pennycook – 2015 Parliamentary Question to the Department of Health

    Matthew Pennycook – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Matthew Pennycook on 2015-10-09.

    To ask the Secretary of State for Health, how many secondary breast cancer patients in (a) England and (b) Greenwich and Woolwich constituency have access to a dedicated clinical nurse specialist.

    Jane Ellison

    The information requested is not collected.